She's been told it's stress for three years.

Irregular periods since she was sixteen. Weight that shifted without explanation. Fatigue that sleep didn't fix. A faint shadow of hair on her face where there hadn't been hair before. Her doctor ordered basic blood work, said the results were normal, and suggested she try to manage her stress levels. She was twenty-six. She was not particularly stressed. She just didn't have a name for what was happening in her body.

Many South Asian women know this story. Symptoms that don't fit neatly into a standard panel. A brief appointment. A suggestion to lose weight or reduce stress. And then years of carrying something that has a name, but was never offered one.

PCOS has affected an estimated one in five South Asian women. That is higher than the global average. And for decades, it has been one of the most underdiagnosed conditions in our community. In May 2026, the medical community formally renamed it. It is now called PMOS. That name change matters more than it might seem at first.

What is PMOS, and why did the name change from PCOS?

After an eleven-year global consensus process involving over 22,000 patients, researchers, and clinicians across 56 professional and patient organizations, polycystic ovary syndrome (PCOS) was officially renamed polyendocrine metabolic ovarian syndrome, or PMOS. The announcement came in May 2026 and was published in The Lancet.

The old name was always a poor description of the condition. Not all women with PCOS have polycystic ovaries. The name directed attention toward the ovaries and away from the systems that drive the condition: the endocrine system and metabolic function. "Polycystic ovary" told you what one imaging result sometimes showed. It didn't tell you what was wrong or why.

PMOS is more accurate. "Polyendocrine" reflects that multiple hormonal systems are involved, including insulin, androgens, and LH. "Metabolic" acknowledges that insulin resistance is a core driver for many women, not a side effect. "Ovarian" keeps the reproductive connection without making it the whole story.

If you were diagnosed with PCOS, nothing about your diagnosis changes. You have the same condition. The treatments remain the same. The symptoms remain the same. The research base remains the same. What changes is that the name now reflects what is happening in your body, which matters for research, diagnosis, and the conversations you have with your doctor. PCOS will remain in use until the International Classification of Diseases updates in 2028. Both terms refer to the same condition.

Why does PMOS affect South Asian women at higher rates?

Research consistently shows that South Asian women are diagnosed with PMOS at higher rates than European populations, and often at lower body weights. Two factors explain most of this.

The first is insulin resistance. South Asian adults have higher rates of insulin resistance and type 2 diabetes than most other ethnic groups, and at lower BMIs. Insulin resistance is a central driver of PMOS for many women: elevated insulin signals the ovaries to produce more androgens, which disrupts ovulation and drives many of the symptoms the condition is known for. When insulin resistance runs in a family, and metabolic risk is higher across the population, PMOS risk is higher too.

The second is delayed diagnosis. South Asian women are less likely to have their symptoms taken seriously, particularly if they don't fit the textbook presentation of someone with PMOS. Symptoms like fatigue, mood changes, irregular cycles, and subtle changes in hair growth are often attributed to stress, diet, or "just how you are." The diagnostic gap is real, and its consequences compound over time. The longer PMOS goes unaddressed, the harder the metabolic picture becomes to manage.

There is also a cultural dimension that doesn't get discussed enough. In many South Asian households, conversations about periods, hormones, and reproductive health happen rarely or not at all. The silence isn't indifference. It's a generation that didn't have the language or the medical access to name what they were living with. Many South Asian women are the first in their families to have a word for what their mothers, aunts, or older sisters also experienced.

One in five South Asian women has PMOS. That is not a niche condition. That is our community.

What does PMOS do in the body?

PMOS is a hormonal and metabolic condition, not primarily a reproductive one, though the reproductive effects are often what bring women to a doctor in the first place.

For most women with PMOS, insulin resistance sits at the center of the picture. The body's cells don't respond to insulin as efficiently, so the pancreas produces more of it. High circulating insulin levels signal the ovaries to produce excess androgens (male hormones, including testosterone). Those androgens interfere with normal ovulation, cause or worsen symptoms like acne and unwanted hair growth, and over time affect mood, weight distribution, and metabolic health.

The hormonal effects don't stop there. LH (luteinizing hormone) is often elevated. Cortisol tends to run higher in women with PMOS, partly because the condition itself is stressful, and partly because insulin resistance and cortisol are connected through shared metabolic pathways. Sleep is frequently disrupted. Mood and anxiety symptoms are more common in women with PMOS than in the general population, and not just as a response to the diagnosis. The hormonal environment itself affects brain chemistry. You can read more about the connection between cortisol and stress in the stress relief supplements post.

This is why PMOS requires a multi-system approach. Addressing only the reproductive symptoms while ignoring the insulin resistance doesn't resolve the underlying picture. And addressing only the metabolic piece while ignoring the mood and sleep effects means women are managing the condition at half capacity.

Which supplements have research behind them for PMOS?

The most-studied supplements for PMOS target insulin sensitivity, androgen balance, inflammation, and the mood and sleep disruptions that accompany the condition. These are not the same as supplements that promise to "balance your hormones" without a mechanism. The ingredients below have clinical evidence behind them at meaningful doses.

Berberine

Berberine has become one of the most well-researched botanical ingredients for PMOS, particularly for its effects on insulin sensitivity. It appears to activate AMPK, the same cellular pathway that metformin (the most commonly prescribed medication for PMOS) activates. Multiple clinical trials have found berberine comparable to metformin for improving insulin sensitivity, reducing androgen levels, and supporting more regular cycles in women with PMOS. For South Asian women whose PMOS picture is driven primarily by insulin resistance, the evidence for berberine is particularly relevant. We covered the broader research on berberine and blood sugar in the insulin resistance supplements article.

Magnesium bisglycinate

Women with PMOS have higher rates of magnesium deficiency than the general population, and insulin resistance accelerates magnesium depletion. Low magnesium worsens insulin resistance, creating a loop that compounds the metabolic picture over time. Magnesium also supports cortisol regulation and sleep quality, two systems that PMOS directly disrupts. The bisglycinate form absorbs far better than the oxide form found in most cheap supplements and is gentler on digestion.

Vitamin D3

Vitamin D deficiency is more prevalent in women with PMOS than in the general population, and South Asian women are already more likely to be deficient due to melanin reducing sunlight-driven vitamin D synthesis. Low vitamin D is associated with worse insulin resistance, more irregular cycles, and lower AMH (anti-Mullerian hormone) in women with PMOS. Correcting a genuine vitamin D deficiency is one of the higher-yield interventions for women with PMOS who haven't been tested. You can read more about why South Asian women are specifically at risk in our post on vitamin D deficiency in South Asian adults.

Saffron

Saffron's most documented effects are on mood and cortisol, which makes it directly relevant to the PMOS picture. Anxiety and depression rates are meaningfully higher in women with PMOS, and they are not just a response to having a difficult diagnosis. The hormonal environment of PMOS, specifically the androgen and cortisol dysregulation, directly affects serotonin pathways. Saffron at 28 to 40mg daily has been studied for mood, anxiety, and HPA axis regulation with consistent results. For South Asian women managing PMOS alongside the mental health stigma that often prevents them from seeking additional support, saffron provides a meaningful, evidence-backed option.

How does Brown Body Reset address PMOS?

BBR wasn't built specifically as a PMOS supplement. It was built to address metabolic health, sleep, and mood in South Asian women, whose bodies exhibit a specific nutritional and hormonal profile. That picture overlaps directly with what PMOS creates in the body.

AM Recharge contains berberine (500mg), chromium picolinate (400mcg), vitamin D3 from lichen (2,000 IU), saffron (20mg), and B12 methylcobalamin (1mg). The morning formula addresses insulin sensitivity, blood sugar stability, vitamin D deficiency, and the energy and mood support that makes functioning through the day possible when PMOS is pulling in the other direction.

PM Restore contains magnesium bisglycinate (714mg, delivering 100mg elemental magnesium), L-theanine (100mg), and saffron (20mg). The evening formula addresses the magnesium deficiency common in PMOS, cortisol and nervous system dysregulation that disrupt sleep, and the continued serotonin support provided by the second saffron dose.

Together, the two formulas cover the metabolic, hormonal, and mood dimensions of PMOS, with a split that reflects how those systems operate at different times of day. It is not a cure. It does not replace medical care or the lifestyle work that managing PMOS requires. It addresses the nutritional floor that makes all of that work more possible.

Frequently asked questions

She eventually got her diagnosis. Not at twenty-six. At thirty-one. Five years after she first described her symptoms to a doctor who told her it was stress.

The condition she had always had finally had a name. And now, because the medical community spent eleven years listening to 22,000 people who deserved better language, it has a more accurate one.

PMOS. Polyendocrine metabolic ovarian syndrome. A name that tells you what is happening in the body instead of what one scan occasionally shows.

The symptoms were never stress. They were never just how you are. They were information. And you deserved someone who knew how to read them.